Treatment of metastatic renal cell carcinoma

被引：0
作者：
David J. Reeves
Chin Y. Liu
机构：
[1] Karmanos Cancer Center,Department of Pharmacy Services
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Bevacizumab; Interferon; Interleukin-2; Renal cell carcinoma; Sorafenib; Sunitinib; Temsirolimus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 25
页数：14
相关论文
共 50 条
[41]   Treatment Algorithm for Metastatic Renal Cell Carcinoma - Recommendations Based on Evidence and Clinical Practice [J].
Bergmann, Lothar ;
Beck, Jochaim ;
Bothe, Kathrin ;
Brinkmann, Olaf A. ;
Buse, Stephan ;
Goebell, Peter J. ;
Gruenwald, Viktor ;
Holzapfel, Konstantin ;
Kuebler, Hubert ;
Marschner, Norbert W. ;
Mickischk, Gerald ;
Schultze-Seemann, Wolfgang ;
Siebels, Michael ;
Siemer, Stephan ;
Stoerkel, Stephan ;
Gschwend, Juergen E. .
ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (03) :136-141
[42]   A Phase II Study of Bevacizumab and Everolimus as Treatment for Refractory Metastatic Renal Cell Carcinoma [J].
Harshman, Lauren C. ;
Barbeau, Sarah ;
McMillian, Alex ;
Srinivas, Sandy .
CLINICAL GENITOURINARY CANCER, 2013, 11 (02) :100-106
[43]   Optimizing treatment for patients with metastatic renal cell carcinoma in the central and Eastern European region [J].
Vrdoljak, Eduard ;
Ciuleanu, Tudor ;
Kharkevich, Galina ;
Mardiak, Jozef ;
Mego, Michal ;
Padrik, Peeter ;
Petruzelka, Lubos ;
Purkalne, Gunta ;
Shparyk, Yaroslav ;
Skrbinc, Breda ;
Szczylik, Cezary ;
Torday, Laszlo .
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (02) :159-174
[44]   Management of Metastatic Renal Cell Carcinoma Progressed After Sunitinib or Another Antiangiogenic Treatment [J].
Iacovelli, Roberto ;
Palazzo, Antonella ;
Trenta, Patrizia ;
Mezi, Silvia ;
Pellegrino, Denise ;
Naso, Giuseppe ;
Cortesi, Enrico .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (06) :611-615
[45]   Current options for the treatment of locally advanced and metastatic renal cell carcinoma: focus on sunitinib [J].
Ravaud, Alain .
EJC SUPPLEMENTS, 2007, 5 (07) :4-11
[46]   A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinoma [J].
Ismail, Salima ;
Meskawi, Malek ;
Hansen, Jens ;
Bianchi, Marco ;
Tian, Zhe ;
Latour, Mathieu ;
Graefen, Markus ;
Montorsi, Francesco ;
Quoc-Dien Trinh ;
Perrotte, Paul ;
Karakiewicz, Pierre I. ;
Sun, Maxine .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 90 (01) :49-57
[47]   An update on targeted therapy in metastatic renal cell carcinoma [J].
Lombardi, Giuseppe ;
Zustovich, Fable ;
Donach, Martin ;
Dalla Palma, Maurizia ;
Nicoletto, Ornella ;
Pastorelli, Davide .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (03) :240-246
[48]   Optimizing recent advances in metastatic renal cell carcinoma [J].
Kevin D. Courtney ;
Toni K. Choueiri .
Current Oncology Reports, 2009, 11 :218-226
[49]   Update on systemic therapies of metastatic renal cell carcinoma [J].
E. Herrmann ;
S. Bierer ;
C. Wülfing .
World Journal of Urology, 2010, 28 :303-309
[50]   Immunotherapy for metastatic renal cell carcinoma [J].
McDermott, David F. ;
Rini, Brian I. .
BJU INTERNATIONAL, 2007, 99 (05) :1282-1288
12345